Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

Upcoming Events

View all
View all
View all
View all
View all
PDA ANSI

PDA and the American National Standards Institute (ANSI)

Read more
What's New
  • New online content just added to the PDA Letter! Does the decrease in visual inspection-related observations and recalls mean less focus on visual inspection? Find out now.
  • Health care stakeholders have called on the U.S. FDA to issue final guidance on interchangeable biosimilars to help promote drug price competition.
  • MHRA continues to consult with the EU in preparation for the March 29, 2019 exit of the United Kingdom from the European Union. The consultation covers contingency planning necessary to make sure the UK’s regulatory processes for medicines, clinical trials, and medical devices are legally coherent in the event no mutually satisfactory agreement between the EU and the UK can be reached.
2019 PDA BoD
Newsfeed
Buyer’s Guide
Become a Member
Lori Richter Volunteer Spotlight Volunteer of the Month is Marc Hogreve
PDA Education

Advertisers

Continue the Conversation @PDA ConnectSM An Interactive Online Community!
PDA Career Center
Open Positions

Director of Regulatory Affairs

This is a non-supervisory role that directs and manages PDA volunteer-driven project activities.

 
Read more

About PDA

The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its nearly 10,000 members worldwide.

Read more

PDA Letter Free Articles